in ewing 's sarcoma and soft tissue sarcoma , the response rate and proportion of patients surviving disease free have been increased ( at least for poor-prognosis patients ) by 15 % to 20 % with an ifosfamide-containing regimen , as used in ongoing trials of the german society of pediatric oncology .
C1261473
soft tissue sarcoma
C0020823
ifosfamide